5,6-trans-Dinoprostone
Modify Date: 2024-01-11 21:05:01
5,6-trans-Dinoprostone structure
|
Common Name | 5,6-trans-Dinoprostone | ||
|---|---|---|---|---|
| CAS Number | 36150-00-2 | Molecular Weight | 352.465 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 530.1±50.0 °C at 760 mmHg | |
| Molecular Formula | C20H32O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 288.5±26.6 °C | |
Use of 5,6-trans-Dinoprostone5-trans-Prostaglandin E2 accelerates fibrinolysis by enhancing plasminogen activation mediated by tissue-type plasminogen activator. It also inhibits platelet aggregation in human PRP. |
| Name | 5-trans Prostaglandin E2 |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 530.1±50.0 °C at 760 mmHg |
| Molecular Formula | C20H32O5 |
| Molecular Weight | 352.465 |
| Flash Point | 288.5±26.6 °C |
| Exact Mass | 352.224976 |
| PSA | 94.83000 |
| LogP | 1.88 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.561 |
| Storage condition | -20°C |
| (5E,13E)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid |
| TRANS-DINOPROSTONE |
| 5-Heptenoic acid, 7-[3-hydroxy-2- (3-hydroxy-1-octenyl)-5-oxocyclopentyl]- |
| 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid |
| prostaglandin-E2 |
| Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5E,13E)- |
| Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5E,11α,13E,15S)- |
| 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid |
| l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid |
| 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- |
| 9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5E,13E-DIEN-1-OIC ACID |
| (5E,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid |
| (5E)-7-{3-Hydroxy-2-[(1E)-3-hydroxy-1-octen-1-yl]-5-oxocyclopentyl}-5-heptenoic acid |
| 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l- |